コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 d stress states, using oxygenation-sensitive cardiovascular magnetic resonance.
2 tolic dysfunction using the gold standard of cardiovascular magnetic resonance.
3 cm(2)]) underwent ECG, echocardiography, and cardiovascular magnetic resonance.
4 derwent combined cardiac catheterization and cardiovascular magnetic resonance.
5 eptal curvature was measured using real-time cardiovascular magnetic resonance.
6 250 consecutive DCM patients with the use of cardiovascular magnetic resonance.
7 individuals 20 to 39 years of age underwent cardiovascular magnetic resonance.
8 quantitative serial perfusion imaging using cardiovascular magnetic resonance.
9 ECGs were obtained within 7.8+/-8.3 weeks of cardiovascular magnetic resonance.
10 and myocardial area at risk were measured by cardiovascular magnetic resonance.
11 nsion not readily detectable by conventional cardiovascular magnetic resonance.
12 intravenous dobutamine administration using cardiovascular magnetic resonance.
13 ng identified by late gadolinium enhancement cardiovascular magnetic resonance.
14 and cardiac function were also measured with cardiovascular magnetic resonance.
15 iomarkers to identify MF without reliance on cardiovascular magnetic resonance.
16 ue-Doppler imaging and speckle tracking, and cardiovascular magnetic resonance.
17 ather than extracellular mass as measured by cardiovascular magnetic resonance.
18 on the right ventricle by contrast-enhanced cardiovascular magnetic resonance.
19 le in preserved left ventricular function by cardiovascular magnetic resonance.
20 patients with AL amyloidosis, underwent LGE cardiovascular magnetic resonance.
21 mass index [BMI], 15.3-59.2 kg/m2) underwent cardiovascular magnetic resonance (1.5 T) to measure RV
22 were retrospectively reviewed (median age at cardiovascular magnetic resonance, 15.4 years; 66.8% mal
23 hanges in right ventricular (RV) mass (using cardiovascular magnetic resonance), 6-minute walk distan
24 tissue characterization in particular gives cardiovascular magnetic resonance a prime role among all
26 e blood flow is proposed and adapted to both cardiovascular magnetic resonance and echocardiographic
27 r outcomes in 1293 HCM patients referred for cardiovascular magnetic resonance and followed up for a
29 een location and extent of RV LGE at in vivo cardiovascular magnetic resonance and histologically doc
30 quiring surgical valve replacement underwent cardiovascular magnetic resonance and intraoperative bio
31 iographically successful PCI predicts MVI at cardiovascular magnetic resonance and reduced myocardial
32 e patients (aged 27+/-7 years) underwent LGE cardiovascular magnetic resonance and were followed for
33 Patients were evaluated by echocardiography, cardiovascular magnetic resonance, and (11)C-acetate pos
34 uding late enhancement, equilibrium contrast cardiovascular magnetic resonance, and clinical cardiac
40 spectively enrolled and repeatedly underwent cardiovascular magnetic resonance at 1.5 T seven days (5
41 l structure and function were assessed using cardiovascular magnetic resonance at 1.5-T in treated HI
42 ion myocardial infarction patients underwent cardiovascular magnetic resonance at 4+/-2 days post pri
43 rated animals (Shams; n=3) were imaged using cardiovascular magnetic resonance at similar time points
44 resented with late gadolinium enhancement on cardiovascular magnetic resonance at the right ventricle
46 Use of blood oxygenation level-dependent cardiovascular magnetic resonance (BOLD-CMR) to assess p
49 estigated whether multiparametric imaging by cardiovascular magnetic resonance can detect differences
50 pectively underwent same day multiparametric cardiovascular magnetic resonance (cine, T2* iron, vasod
51 sional (3D) whole heart myocardial perfusion cardiovascular magnetic resonance (CMR) against invasive
52 he relation of BMI to LV mass, determined by cardiovascular magnetic resonance (CMR) and heart failur
53 oninvasive imaging methods of fibrosis using cardiovascular magnetic resonance (CMR) and nuclear imag
54 this study was to compare fully quantitative cardiovascular magnetic resonance (CMR) and positron emi
55 d the sex-specific diagnostic performance of cardiovascular magnetic resonance (CMR) and single-photo
56 re no prospective, prognostic data comparing cardiovascular magnetic resonance (CMR) and single-photo
57 acterize the current training environment in cardiovascular magnetic resonance (CMR) and vascular ima
63 with follow-up until December 14, 2015, at a cardiovascular magnetic resonance (CMR) center serving a
65 isual interpretation algorithm that combines cardiovascular magnetic resonance (CMR) data from perfus
66 ed to identify the optimal cut-off of TEI by cardiovascular magnetic resonance (CMR) for defining via
67 he diagnostic performance of multiparametric cardiovascular magnetic resonance (CMR) for detecting ca
69 rmation on the latest scientific advances in cardiovascular magnetic resonance (CMR) from mice to man
70 infarct detection based on contrast-enhanced cardiovascular magnetic resonance (CMR) has higher spati
71 nary angiography, and, most recently, stress cardiovascular magnetic resonance (CMR) have enhanced th
72 ch as positron emission tomography (PET) and cardiovascular magnetic resonance (CMR) have led to an e
74 t to evaluate high-resolution black-blood 3D cardiovascular magnetic resonance (CMR) imaging for in v
76 ecent case reports using delayed-enhancement cardiovascular magnetic resonance (CMR) imaging raise th
77 pared the diagnostic accuracy of postmortem, cardiovascular magnetic resonance (CMR) imaging with con
79 cement (MWHE) on late gadolinium enhancement cardiovascular magnetic resonance (CMR) imaging, predict
80 ricular contraction patterns were defined by cardiovascular magnetic resonance (CMR) imaging, usually
81 tudy was undertaken to evaluate the value of cardiovascular magnetic resonance (CMR) in the assessmen
83 tanding of the reader on the applications of cardiovascular magnetic resonance (CMR) in transcatheter
84 ue heterogeneity of myocardial infarction by cardiovascular magnetic resonance (CMR) is associated wi
87 tudy sought to determine the relationship of cardiovascular magnetic resonance (CMR) measures of tiss
93 tent of late gadolinium enhancement (LGE) by cardiovascular magnetic resonance (CMR) predict adverse
94 dy, we assessed the diagnostic accuracy of a cardiovascular magnetic resonance (CMR) protocol incorpo
95 the diagnostic accuracy of a multiparametric cardiovascular magnetic resonance (CMR) protocol with x-
96 own or suspected myocardial infarction (MI), cardiovascular magnetic resonance (CMR) provides a compr
99 athletes, and 20 healthy controls underwent cardiovascular magnetic resonance (CMR) scanning at 3-T.
101 ance of novel quantitative T1 and T2 mapping cardiovascular magnetic resonance (CMR) techniques to id
102 tion of left ventricular (LV) hypertrophy by cardiovascular magnetic resonance (CMR) to more precisel
108 etected by late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) would be present
109 inferobasal myocardium have been detected by cardiovascular magnetic resonance (CMR), but the extent
110 ine whether myocardial fibrosis, detected by cardiovascular magnetic resonance (CMR), represents an a
111 Myocardial relaxation was evaluated from cardiovascular magnetic resonance (CMR)-based rho, a pre
114 and computer simulations showed that CP-BOLD cardiovascular magnetic resonance could be useful in det
115 fusion territories using CE-SSFP and T2-STIR cardiovascular magnetic resonance data in patients after
116 tudy was to assess the utility of dobutamine cardiovascular magnetic resonance (DCMR) results for pre
118 We examined whether delayed-enhancement cardiovascular magnetic resonance (DE-CMR) coronary arte
121 ed by subsecond delayed contrast-enhancement cardiovascular magnetic resonance during free breathing
122 imodal cardiac assessment: contrast-enhanced cardiovascular magnetic resonance, echocardiograms, 24-h
123 rs (age, 4-57 years) free from PVR underwent cardiovascular magnetic resonance, echocardiography, and
125 DI] S-wave R=0.52, P<0.001) and conventional cardiovascular magnetic resonance (eg, indexed left vent
127 tion, little information is available on the cardiovascular magnetic resonance findings in this popul
131 drop at the aortic valve using 3-dimensional cardiovascular magnetic resonance flow data in 32 subjec
133 ften requiring a high index of suspicion and cardiovascular magnetic resonance for identification.
134 thy without history of CHF were studied with cardiovascular magnetic resonance for late gadolinium en
135 % and extracardiac sarcoidosis who underwent cardiovascular magnetic resonance for LGE evaluation.
136 patients (mean age, 40+/-9 years) underwent cardiovascular magnetic resonance for routine assessment
137 osis detected by late gadolinium enhancement cardiovascular magnetic resonance for the prediction of
138 stem, and externally irrigated ablation with cardiovascular magnetic resonance guidance to undertake
142 d standard in arrhythmogenic cardiomyopathy, cardiovascular magnetic resonance has received a more gu
143 nnual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance, held in San Francisco
144 ed whether late gadolinium enhancement (LGE) cardiovascular magnetic resonance identified patients wi
145 t trabeculae measured by fractal analysis of cardiovascular magnetic resonance images are abnormal in
146 al signal intensity in oxygenation-sensitive cardiovascular magnetic resonance images of the midapica
147 First-pass CT images and contrast-enhanced cardiovascular magnetic resonance images were acquired i
150 lood lactate analysis, and contrast-enhanced cardiovascular magnetic resonance imaging (cine, tagging
151 We hypothesized that gadolinium-enhanced cardiovascular magnetic resonance imaging (CMR) can pred
154 ass and systolic and diastolic function with cardiovascular magnetic resonance imaging and echocardio
156 perglycemia on myocardial damage assessed by cardiovascular magnetic resonance imaging and to evaluat
159 chest and abdominal computed tomography and cardiovascular magnetic resonance imaging between 2002 a
162 s with a history of frequent PVCs undergoing cardiovascular magnetic resonance imaging had real-time
165 is identified by late gadolinium enhancement cardiovascular magnetic resonance imaging in approximate
169 omplicated pericarditis; 2) in select cases, cardiovascular magnetic resonance imaging may aid in the
171 t-elevation myocardial infarction, underwent cardiovascular magnetic resonance imaging on day 3 and m
172 -diastolic volume index measured by means of cardiovascular magnetic resonance imaging or multirow de
173 ction during 3-year follow-up, determined by cardiovascular magnetic resonance imaging or, in patient
175 rformed using a 2-dimensional (2D) real-time cardiovascular magnetic resonance imaging technique.
177 This review will highlight some recent novel cardiovascular magnetic resonance imaging techniques, co
178 uterized tomographic coronary angiogram, and cardiovascular magnetic resonance imaging with late gado
179 he cardiac cycle in healthy volunteers using cardiovascular magnetic resonance imaging, and (c) to ca
180 rs; interquartile range, 18 years) underwent cardiovascular magnetic resonance imaging, which was per
195 in brachial artery area were measured using cardiovascular magnetic resonance in 13 amenorrheic DMPA
196 was assessed with the use of myocardial T2* cardiovascular magnetic resonance in 167 patients with t
197 trophic cardiomyopathy phenotype measured by cardiovascular magnetic resonance in a multicenter envir
199 olved blood oxygen level-dependent (CP-BOLD) cardiovascular magnetic resonance in detecting myocardia
201 raphy in only 16 of 28 patients (57%) but by cardiovascular magnetic resonance in the 12 patients und
203 o-date perspective on the diagnostic role of cardiovascular magnetic resonance in the genetics era.
207 ge 65 years) underwent conventional clinical cardiovascular magnetic resonance, including late enhanc
208 es investigating the impact of correction of cardiovascular magnetic resonance indices for age and se
209 s as measured by late gadolinium enhancement cardiovascular magnetic resonance is an independent pred
210 lium-dependent arterial function measured by cardiovascular magnetic resonance is impaired in chronic
212 tations that may be overcome by adding newer cardiovascular magnetic resonance mapping techniques.
213 are limited data on the prognostic value of cardiovascular magnetic resonance measurements in idiopa
214 Consideration should be given to correcting cardiovascular magnetic resonance measures for age, sex,
215 Concordant with previous animal studies, cardiovascular magnetic resonance measures of contrast-e
216 circumference, were examined in relation to cardiovascular magnetic resonance measures of left ventr
218 Each participant underwent phase-contrast cardiovascular magnetic resonance measures of pulse wave
221 nal functional markers derived from standard cardiovascular magnetic resonance (MR) images for their
223 on angiogenesis and arteriogenesis by using cardiovascular magnetic resonance (MR) imaging for evalu
225 -pass perfusion and late gadolinium-enhanced cardiovascular magnetic resonance (MR) imaging to detect
228 e-related cardiotoxicity model, increases in cardiovascular magnetic resonance myocardial contrast-en
230 plications, accuracy, and reproducibility of cardiovascular magnetic resonance myocardial feature tra
231 ubjects were studied by echocardiography and cardiovascular magnetic resonance (n=55 of 67 ToF patien
233 actice of monitoring cardiac iron in vivo by cardiovascular magnetic resonance of the midseptum.
234 single-photon emission computed tomography, cardiovascular magnetic resonance offers superior image
235 utaneous coronary intervention and underwent cardiovascular magnetic resonance on a 1.5-T scanner at
236 right ventricular structure and function by cardiovascular magnetic resonance on a 1.5-T Siemens sca
237 ic (Hemo+) infarctions, as determined by T2* cardiovascular magnetic resonance on day 3 (n=11), showe
238 ischemia-reperfusion injury (n=14) underwent cardiovascular magnetic resonance on days 3 and 56 after
239 ate gadolinium enhancement (LGE) assessed by cardiovascular magnetic resonance on left ventricular (L
241 ntrol study investigated crypts and 22 other cardiovascular magnetic resonance parameters in subclini
242 emonstrated the usefulness of phase-contrast cardiovascular magnetic resonance (PC-CMR) in noninvasiv
243 ergoing PVR were prospectively recruited for cardiovascular magnetic resonance performed before PVR (
246 etected by late gadolinium enhancement (LGE) cardiovascular magnetic resonance predicts outcomes in p
247 xtracellular volume measures acquired during cardiovascular magnetic resonance promises to transform
248 nd G+P- subjects (n=23) underwent a clinical cardiovascular magnetic resonance protocol (3 tesla) for
250 of our study was to evaluate a comprehensive cardiovascular magnetic resonance protocol, including la
252 erload and provide calibration in humans for cardiovascular magnetic resonance R2* against myocardial
256 ts with a low pretest probability and normal cardiovascular magnetic resonance served as a control gr
257 ransposition of the great arteries, thus LGE cardiovascular magnetic resonance should be incorporated
258 ine breath-hold delayed contrast-enhancement cardiovascular magnetic resonance (standard) in consecut
259 indexed to body surface area was measured by cardiovascular magnetic resonance steady-state free prec
260 ed healthy controls) underwent comprehensive cardiovascular magnetic resonance studies, including nat
261 nts with constrictive pericarditis who had a cardiovascular magnetic resonance study with DHE prior t
265 An ultrafast, delayed contrast-enhancement cardiovascular magnetic resonance technique that can acq
266 ship with outcomes, we used novel, validated cardiovascular magnetic resonance techniques to quantify
268 DM and 20 matched control subjects underwent cardiovascular magnetic resonance to assess LV remodelin
269 r AVR using echocardiography to measure AVA, cardiovascular magnetic resonance to assess LVM, and pos
272 ations, the authors discuss the potential of cardiovascular magnetic resonance to inform treatment du
274 g echocardiography to assess severity of AS, cardiovascular magnetic resonance to measure left ventri
275 Beyond accurate diagnosis, the value of cardiovascular magnetic resonance to predict the outcome
276 ical evaluation, late gadolinium enhancement cardiovascular magnetic resonance, TTN sequencing, and a
277 the clinical performance of adenosine stress cardiovascular magnetic resonance using this new perfusi
278 itral valve areas (MVAs) by velocity-encoded cardiovascular magnetic resonance (VE-CMR) and to compar
279 s showed that the absence of LGE at baseline cardiovascular magnetic resonance was a strong predictor
281 The relationship between ECG strain and cardiovascular magnetic resonance was then assessed in a
285 onischemic dilated cardiomyopathy undergoing cardiovascular magnetic resonance were followed for the
286 ated to estimate myocardium at risk (MaR) by cardiovascular magnetic resonance while using myocardial
290 nal intensities evident on contrast-enhanced cardiovascular magnetic resonance with late gadolinium e
291 ited 793 consecutive patients at the time of cardiovascular magnetic resonance without amyloidosis or
292 hypothesized that noncontrast T1 mapping by cardiovascular magnetic resonance would provide a novel
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。